Company intelligence
Fortitude Biomedicines
Developing next-generation biotherapeutics to address unmet medical needs.
About Fortitude Biomedicines
Fortitude Biomedicines is a private biotechnology company headquartered in Waltham, Massachusetts, pioneering next-generation immune cell targeting biologics and an antibody–drug conjugate (ADC) platform powered by proprietary molecular glue payloads. By integrating the precision targeting of ADCs with the catalytic power of targeted protein degradation, the company is developing transformative therapies with the potential to expand the therapeutic window of ADCs, overcome resistance mechanisms, and unlock new target space. Leveraging a robust discovery engine and an experienced team of drug hunters, Fortitude is building a differentiated pipeline of biologics and ADCs aimed at delivering meaningful benefits to patients with high unmet medical need. Investor Relations and Media Contact IR@fortitudebio.com
Verified activity
Signals from Fortitude Biomedicines
1 published signal